Riskpilot← Back to searchSign inGet full accessOtolab AB
ABActiveOrg 5563511012Metallgatan 2 CManufacture of irradiation, electromedical and electrotherapeutic equipment · NACE 2660Est. 19893 employees
Revenue 2025
SEK 2,8M
+2% vs 2024
EBITDA margin
-2.2%
+63% vs 2024
Equity ratio
82.4%
Financial strength
Net profit 2025
SEK -63K
+70% vs 2024
| Revenue | SEK 2,8M | +2% |
| EBITDA | SEK -63K | +63% |
| Net profit | SEK -63K | +70% |
| Total assets | SEK 1,5M | -2% |
| Equity | SEK 1,2M | -5% |
| Employees | 3 | — |
Legal name
Otolab AB
Org number
5563511012
Legal form
Aktiebolag
NACE code
2660 · Manufacture of irradiation, electromedical and electrotherapeutic equipment
Founded
6 februari 1989
Share capital
SEK 100 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva tillverkning och service av hörselinsatser och hörapparater detaljhandel med häst- och ryttarutrustning, värdepappersförvaltning, fastighetsförvaltning samt därmed förenlig verksamhet.
Address
Metallgatan 2 C
Phone
+4643175333
Email
info@otolab.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 884 | 2 790 | 2 583 | 2 773 | 2 828 |
| Staff expenses | — | — | −1 912 | −1 910 | −1 929 |
| EBITDA | 281 | 175 | −276 | −171 | −63 |
| Depreciation & amort. | −94 | −75 | −59 | −39 | −31 |
| EBIT | 187 | 100 | −335 | −211 | −94 |
| Net financials | — | −1 | 2 | −1 | 30 |
| Profit before tax | 186 | 99 | −333 | −211 | −63 |
| Tax | −0 | −0 | — | — | — |
| Net profit | 186 | 99 | −333 | −211 | −63 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 211 | 2 077 | 1 707 | 1 539 | 1 503 |
| Equity | 1 946 | 1 846 | 1 512 | 1 301 | 1 238 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 265 | 231 | 194 | 238 | 265 |
| Total debt | 265 | 231 | 194 | 238 | 265 |
EBITDA margin
-2.2%
This company
15.8%
Market median
-114% vs market
20212025
Equity ratio
82.4%
This company
38.2%
Market median
+116% vs market
20212025
Return on equity
-5.1%
This company
18.4%
Market median
-128% vs market
20212025
Net profit margin
-2.2%
This company
8.1%
Market median
-127% vs market
20212025
Asset turnover
1.88×
This company
1.12×
Market median
+68% vs market
20212025
Debt / equity
0.21×
This company
0.62×
Market median
+66% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
PS Audit | Audit | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Deputy Board Member | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Otolab AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Paul Stefan Paulsson | Audit | 0 companies |
| John Eiler Corneliusson | Board of Directors | 0 companies |
| Kjell Bertil Marcus Wiberg | Deputy Board Member | 0 companies |